Our finding that STAT5B’s strongest survival associations occur in cancers with frequent epigenetic dysregulation (e.g., DLBCL, LUAD) raises the hypothesis that uSTAT5B contributes to heterochromatin stability. This evidence concerns the gene STAT5B and cancer.